ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder

NCT07169162 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Enrollment never started

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: ADZENYS XR-ODT
DRUG: Placebo Oral Tablet

Sponsor

Aytu BioPharma, Inc.

Collaborators

[object Object]